174 related articles for article (PubMed ID: 29318471)
1. AAV-mediated gene delivery of the calreticulin anti-angiogenic domain inhibits ocular neovascularization.
Tu L; Wang JH; Barathi VA; Prea SM; He Z; Lee JH; Bender J; King AE; Logan GJ; Alexander IE; Bee YS; Tai MH; Dusting GJ; Bui BV; Zhong J; Liu GS
Angiogenesis; 2018 Feb; 21(1):95-109. PubMed ID: 29318471
[TBL] [Abstract][Full Text] [Related]
2. Gene Delivery of Calreticulin Anti-Angiogenic Domain Attenuates the Development of Choroidal Neovascularization in Rats.
Bee YS; Tu L; Sheu SJ; Lin HC; Tang JH; Wang JH; Prea SM; Dusting GJ; Wu DC; Zhong J; Bui BV; Tai MH; Liu GS
Hum Gene Ther; 2017 May; 28(5):403-414. PubMed ID: 28363247
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Experimental Choroidal Neovascularization by a Novel Peptide Derived from Calreticulin Anti-Angiogenic Domain.
Bee YS; Ma YL; Chen J; Tsai PJ; Sheu SJ; Lin HC; Huang H; Liu GS; Tai MH
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274378
[TBL] [Abstract][Full Text] [Related]
4. Reduction of choroidal neovascularization in mice by adeno-associated virus-delivered anti-vascular endothelial growth factor short hairpin RNA.
Askou AL; Pournaras JA; Pihlmann M; Svalgaard JD; Arsenijevic Y; Kostic C; Bek T; Dagnaes-Hansen F; Mikkelsen JG; Jensen TG; Corydon TJ
J Gene Med; 2012 Nov; 14(11):632-41. PubMed ID: 23080553
[TBL] [Abstract][Full Text] [Related]
5. Development of gene therapy for treatment of age-related macular degeneration.
Askou AL
Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
[TBL] [Abstract][Full Text] [Related]
6. Effect of subretinal injection on retinal structure and function in a rat oxygen-induced retinopathy model.
Becker S; Wang H; Stoddard GJ; Hartnett ME
Mol Vis; 2017; 23():832-843. PubMed ID: 29259390
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor-B gene transfer exacerbates retinal and choroidal neovascularization and vasopermeability without promoting inflammation.
Zhong X; Huang H; Shen J; Zacchigna S; Zentilin L; Giacca M; Vinores SA
Mol Vis; 2011 Feb; 17():492-507. PubMed ID: 21364963
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of retinal neovascularization by intraocular viral-mediated delivery of anti-angiogenic agents.
Auricchio A; Behling KC; Maguire AM; O'Connor EM; Bennett J; Wilson JM; Tolentino MJ
Mol Ther; 2002 Oct; 6(4):490-4. PubMed ID: 12377190
[TBL] [Abstract][Full Text] [Related]
9. Animal models of ocular angiogenesis: from development to pathologies.
Liu CH; Wang Z; Sun Y; Chen J
FASEB J; 2017 Nov; 31(11):4665-4681. PubMed ID: 28739642
[TBL] [Abstract][Full Text] [Related]
10. Ilimaquinone inhibits neovascular age-related macular degeneration through modulation of Wnt/β-catenin and p53 pathways.
Son Y; Lim D; Park S; Song IS; Kim JH; Shin S; Jang H; Liu KH; O Y; Song GY; Kang W; Cho YS; Na M; Chung H; Oh S
Pharmacol Res; 2020 Nov; 161():105146. PubMed ID: 32814173
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy for ocular angiogenesis.
Bainbridge JW; Mistry AR; Thrasher AJ; Ali RR
Clin Sci (Lond); 2003 Jun; 104(6):561-75. PubMed ID: 12570869
[TBL] [Abstract][Full Text] [Related]
12. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
13. Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization.
Pechan P; Rubin H; Lukason M; Ardinger J; DuFresne E; Hauswirth WW; Wadsworth SC; Scaria A
Gene Ther; 2009 Jan; 16(1):10-6. PubMed ID: 18633446
[TBL] [Abstract][Full Text] [Related]
14. Overexpressing kringle 1 domain of hepatocyte growth factor with adeno-associated virus inhibits the pathological retinal neovascularization in an oxygen-induced retinopathy mouse model.
Sun P; Liu Z
Biochem Biophys Res Commun; 2019 Jan; 508(1):130-137. PubMed ID: 30471863
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic activity of aganirsen in nonhuman primate and rodent models of retinal neovascular disease after topical administration.
Cloutier F; Lawrence M; Goody R; Lamoureux S; Al-Mahmood S; Colin S; Ferry A; Conduzorgues JP; Hadri A; Cursiefen C; Udaondo P; Viaud E; Thorin E; Chemtob S
Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1195-203. PubMed ID: 22323484
[TBL] [Abstract][Full Text] [Related]
16. Combined fluorescein angiography and spectral-domain optical coherence tomography imaging of classic choroidal neovascularization secondary to age-related macular degeneration before and after intravitreal ranibizumab injections.
Coscas F; Querques G; Forte R; Terrada C; Coscas G; Souied EH
Retina; 2012 Jun; 32(6):1069-76. PubMed ID: 22466476
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
Seo S; Suh W
Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
[TBL] [Abstract][Full Text] [Related]
18. Retinal function in eyes with proliferative diabetic retinopathy treated with intravitreal ranibizumab and multispot laser panretinal photocoagulation.
Messias K; Barroso RM; Jorge R; Messias A
Doc Ophthalmol; 2018 Oct; 137(2):121-129. PubMed ID: 30209775
[TBL] [Abstract][Full Text] [Related]
19. Topical application of recombinant calreticulin peptide, vasostatin 48, alleviates laser-induced choroidal neovascularization in rats.
Bee YS; Sheu SJ; Ma YL; Lin HC; Weng WT; Kuo HM; Hsu HC; Tang CH; Liou JC; Tai MH
Mol Vis; 2010 Apr; 16():756-67. PubMed ID: 20454694
[TBL] [Abstract][Full Text] [Related]
20. REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Dolz-Marco R; Phasukkijwatana N; Sarraf D; Freund KB
Retina; 2017 Feb; 37(2):222-233. PubMed ID: 27627752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
